Peter W. Fan
University of Illinois at Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter W. Fan.
Chemical Research in Toxicology | 2011
Chenghong Zhang; Jane R. Kenny; Hoa Le; Alan Deese; Kevin A. Ford; Luke K. Lightning; Peter W. Fan; James P. Driscoll; Jason S. Halladay; Cornelis E. C. A. Hop; S. Cyrus Khojasteh
The objective of the present study was to investigate the influence of halogen position on the formation of reactive metabolites from dihalogenated anilines. Herein we report on a proposed mechanism for dehalogenation and glutathione (GSH) conjugation of a series of ortho-, meta-, and para-dihalogenated anilines observed in human liver microsomes. Of particular interest were conjugates formed in which one of the halogens on the aniline was replaced by GSH. We present evidence that a (4-iminocyclohexa-2,5-dienylidene)halogenium reactive intermediate (QX) was formed after oxidation, followed by ipso addition of GSH at the imine moiety. The ipso GSH thiol attacks at the ortho-carbon and eventually leads to a loss of a halogen and GSH replacement. The initial step of GSH addition at the ipso position is also supported by density functional theory, which suggests that the ipso carbon of the chloro, bromo, and iodo (but not fluoro) containing 2-fluoro-4-haloanilines is the most positive carbon and that these molecules have the favorable highest occupied molecular orbital of the aniline and the lowest unoccupied orbital from GSH. The para-substituted halogen (chloro, bromo, or iodo but not fluoro) played a pivotal role in the formation of the QX, which required a delocalization of the positive charge on the para-halogen after oxidation. This mechanism was supported by structure-metabolism relationship analysis of a series of dihalogenated and monohalogenated aniline analogues.
Drug Metabolism Letters | 2016
Hoa Le; Peter W. Fan; Susan Wong; Shuguang Ma; James P. Driscoll; Cornelis E. C. A. Hop; S. Cyrus Khojasteh
BACKGROUND Tofacitinib is known to generate two metabolites M2 (alcohol) and M4 (acid), which are formed as the result of oxidation and loss of the nitrile [1]. METHOD Systematic in vitro investigation into generation of M2 and M4 from tofacitinib. RESULTS In vitro using human liver microsomes, we found a new geminal diol metabolite of tofacitinib (MX) that lost the nitrile. MX was further reduced or oxidized to M2 (alcohol) and M4 (acid), respectively by enzymes such as aldo-keto reductase 1C1, aldehyde oxidase and possibly CYP3A4. Stable label studies using H2 18O and D2O suggested the source of oxygen was from water in the media. This was due to rapid water exchange with MX in the media prior to reduction to M2. In case of deuterium, one was incorporated in M2 and this was mainly as a result of tofacitinib rapid exchange of two deuterium atoms from D2O onto methylene position. After formation of MX, there was one deuterium that no longer exchanged with water and therefore retained in M2 for further reduction. CONCLUSION The proposed mechanism involved the initial oxidation by P450 at the α-carbon to the nitrile group generating an unstable cyanohydrin intermediate; followed by the loss of the nitrile group to form a new geminal diol metabolite (MX).
Xenobiotica | 2013
Hoa Le; Kevin A. Ford; S. Cyrus Khojasteh; Peter W. Fan
1. Here we report on the mechanism of ribose conjugation, through NADH as a cofactor, of a pyrazole-containing compound (PT). Incubation of PT in rat liver microsomes supplemented with NADP+/H, NAD+/H, and β-nicotinamide mononucleotide (NMN) resulted in complete conjugation to the adenine dinucleotide phosphate conjugate (ADP-C), adenine dinucleotide conjugate (AD-C), and 5-phosphoribose conjugate (Rib-C1), respectively. In hepatocytes, PT predominantly formed three ribose conjugates: Rib-C1, the ribose conjugate (Rib-C2), and the carboxylic acid of Rib-C2 (Rib-C3). 2. Phosphatase inhibitors were added to hepatocyte incubations. AD-C was detected in this reaction, which suggests that one of the major pathways for the formation of the ribose conjugates is through NAD+/H. When AD-C was incubated with phosphatase, Rib-C1 and Rib-C2 formed. 3. To understand the in vivo relevance of this metabolic pathway, rats were dosed with PT and Rib-C2 was found in the urine. 4. Structure–activity relationship shows that replacement of the distal thiazole group in the PT to a phenyl group abolishes this conjugation. Three amino acid residues in the active site preferentially interact with the sulfur atom in the thiazole of PT. 5. In summary, PT forms direct AD-C in hepatocytes, which is further hydrolyzed by phosphatase to give ribose conjugates.
Drug Metabolism and Disposition | 2002
Daniel C. Kemp; Peter W. Fan; Jeffrey C. Stevens
Chemical Research in Toxicology | 2000
Peter W. Fan; and Fagen Zhang; Judy L. Bolton
Chemical Research in Toxicology | 2000
Fagen Zhang; Peter W. Fan; Xuemei Liu; Lixin Shen; Richard B. van Breemen; Judy L. Bolton
Drug Metabolism and Disposition | 2001
Peter W. Fan; Judy L. Bolton
ACS Medicinal Chemistry Letters | 2016
Donglu Zhang; Thomas H. Pillow; Yong Ma; Josefa dela Cruz-Chuh; Katherine R. Kozak; Jack Sadowsky; Gail Lewis Phillips; Jun Guo; Martine Darwish; Peter W. Fan; Jingtian Chen; Changrong He; Tao Wang; Hui Yao; Zijin Xu; Jinhua Chen; John Wai; Zhonghua Pei; Cornelis E. C. A. Hop; S. Cyrus Khojasteh; Peter S. Dragovich
Combinatorial Chemistry & High Throughput Screening | 1999
Dejan Nikolic; Peter W. Fan; Judy L. Bolton; van Breemen Rb
Journal of the American Chemical Society | 1998
Cristina Sanchez; Shinya Shibutani; Lakkaraju Dasaradhi; Judy L. Bolton; Peter W. Fan; Robert A. McClelland